Floatz logo

Vinorelbine

Metastatic Adrenal Gland Pheochromocytoma

Vanderbilt-Ingram Cancer CenterPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Metastatic Adrenal Gland Pheochromocytoma cohort.

Asset / SponsorPhaseRating
Oxodotreotide
M.D. Anderson Cancer Center
Phase 2CCC
Pembrolizumab
M.D. Anderson Cancer Center
Phase 2CCC
Cyclophosphamide
M.D. Anderson Cancer Center
Phase 2CCC
Epirubicin
M.D. Anderson Cancer Center
Phase 2CCC
Eloxatin
Vanderbilt-Ingram Cancer Center
Phase 1CC

View all 9 →

Same molecule, other indications

Vinorelbine is also rated in:

HER2 positive breast carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →
Recurrent Breast CarcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →